PSI-developed drug could increase survival chances for metastatic prostate cancer patients
Researchers at PSI have developed a new drug that could increase the survival chances of patients with metastatic prostate cancer.
Source: news-medical.net
Radiopharmaceutical Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Radiopharmaceutical Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Radiopharmaceutical Sciences Today - Breaking & Trending Today
Perspective Therapeutics to Present at the 2023
Three poster presentations from Perspective Therapeutics’ scientists and collaborators explore combinations of immunotherapy and targeted alpha-particle...
Source: globenewswire.com
PSI researchers optimize a method for tumor diagnosis using radionuclides
Researchers at the Paul Scherrer Institute PSI, in collaboration with ETH Zurich, have optimized a method for tumor diagnosis using radionuclides.
Source: news-medical.net
Clarity Pharmaceuticals begins phase II trial using SAR-Bombesin as prostate cancer diagnostic
Clarity Pharmaceuticals (ASX: CU6) has begun its phase II diagnostic trial for patients with prostate cancer using its Copper-64 SAR-Bombesin product in imaging scans.
Source: smallcaps.com.au
First Patients Dosed with Illuccix® - Telix's Approved Prostate Cancer Imaging Agent
/PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces first commercial doses of its prostate cancer imaging agent,...
Source: prnewswire.com